Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.
about
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Sustained platelet-sparing eff ...... ory epithelial ovarian cancer.
@ast
Sustained platelet-sparing eff ...... ory epithelial ovarian cancer.
@en
type
label
Sustained platelet-sparing eff ...... ory epithelial ovarian cancer.
@ast
Sustained platelet-sparing eff ...... ory epithelial ovarian cancer.
@en
prefLabel
Sustained platelet-sparing eff ...... ory epithelial ovarian cancer.
@ast
Sustained platelet-sparing eff ...... ory epithelial ovarian cancer.
@en
P2093
P2860
P356
P1433
P1476
Sustained platelet-sparing eff ...... tory epithelial ovarian cancer
@en
P2093
Janet Graham
Rohini Sharma
Sarah Blagden
P2860
P2888
P356
10.1186/1471-2407-11-289
P407
P50
P577
2011-07-11T00:00:00Z
P5875
P6179
1041076804